AAAAAA

   
Results: 1-21 |
Results: 21
PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS
Authors: DEMETER LM MEEHAN PM MORSE G FISCHL MA PARA M POWDERLY W LEEDOM J HOLDENWILTSE J GREISBERGER C WOOD K TIMPONE J WATHEN LK NEVIN T RESNICK L BATTS DH REICHMAN RC
Citation: Lm. Demeter et al., PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 135-144
A RANDOMIZED, DOUBLE-BLIND TRIAL OF VALACICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: FEINBERG JE HURWITZ S COOPER D SATTLER FR MACGREGOR RR POWDERLY W HOLLAND GN GRIFFITHS PD POLLARD RB YOULE M GILL MJ HOLLAND FJ POWER ME OWENS S COAKLEY D FRY J JACOBSON MA
Citation: Je. Feinberg et al., A RANDOMIZED, DOUBLE-BLIND TRIAL OF VALACICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 177(1), 1998, pp. 48-56
ITRACONAZOLE MAINTENANCE TREATMENT FOR HISTOPLASMOSIS IN AIDS - A PROSPECTIVE, MULTICENTER TRIAL
Authors: HECHT FM WHEAT J KORZUN AH HAFNER R SKAHAN KJ LARSEN R LIMJOCO MT SIMPSON M SCHNEIDER D KEEFER MC CLARK R LAI KK JACOBSON JM SQUIRES K BARTLETT JA POWDERLY W
Citation: Fm. Hecht et al., ITRACONAZOLE MAINTENANCE TREATMENT FOR HISTOPLASMOSIS IN AIDS - A PROSPECTIVE, MULTICENTER TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 16(2), 1997, pp. 100-107
PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: MASUR H KAPLAN JE HOLMES KK BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Clinical infectious diseases, 25, 1997, pp. 299
1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: MASUR H KAPLAN JE HOLMES KK ARMSTRONG D BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 25, 1997, pp. 313-335
THE SAFETY AND PHARMACOKINETICS OF SINGLE-AGENT AND COMBINATION THERAPY WITH MEGESTROL-ACETATE AND DRONABINOL FOR THE TREATMENT OF HIV WASTING SYNDROME
Authors: TIMPONE JG WRIGHT DJ LI N EGORIN MJ ENAMA ME MAYERS J GALETTO G GAGNON S VARGO J CHIRGWIN K MARCEL A COHN D HOPKINS B DUDLEY M GELETKO S STANDIFORD H CERVINO K MUSHATT DM GREENSPAN D POWDERLY W MEYERS M SAMPSON JH MCMILLAN G NOVAK R MOREIRA L
Citation: Jg. Timpone et al., THE SAFETY AND PHARMACOKINETICS OF SINGLE-AGENT AND COMBINATION THERAPY WITH MEGESTROL-ACETATE AND DRONABINOL FOR THE TREATMENT OF HIV WASTING SYNDROME, AIDS research and human retroviruses, 13(4), 1997, pp. 305-315
LONG-TERM EFFICACY AND SAFETY OF DRONABINOL FOR ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED ANOREXIA
Authors: BEAL JE OLSON R LEFKOWITZ L LARENSTEIN L BELLMAN P YANGCO B MORALES JO MURPHY R POWDERLY W PLASSE TF MOSDELL KW SHEPARD KV
Citation: Je. Beal et al., LONG-TERM EFFICACY AND SAFETY OF DRONABINOL FOR ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED ANOREXIA, Journal of pain and symptom management, 14(1), 1997, pp. 7-14
UTILITY OF URINE AND LEUKOCYTE-CULTURES AND PLASMA DNA-POLYMERASE CHAIN-REACTION FOR IDENTIFICATION OF AIDS PATIENTS AT RISK FOR DEVELOPINGHUMAN CYTOMEGALOVIRUS DISEASE
Authors: SHINKAI M BOZZETTE SA POWDERLY W FRAME P SPECTOR SA
Citation: M. Shinkai et al., UTILITY OF URINE AND LEUKOCYTE-CULTURES AND PLASMA DNA-POLYMERASE CHAIN-REACTION FOR IDENTIFICATION OF AIDS PATIENTS AT RISK FOR DEVELOPINGHUMAN CYTOMEGALOVIRUS DISEASE, The Journal of infectious diseases, 175(2), 1997, pp. 302-308
MSL-109 ADJUVANT THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY IN SYNDROME - THE MONOCLONAL-ANTIBODY CYTOMEGALOVIRUS RETINITIS TRIAL
Authors: LEWIS RA CARRHOLDEN LM DOYLE K FAINSTEIN V GARDNER N GROSS R ORENGONANIA S PATEL V SAMO TC SHIGLEY JW SHAWVER L SPENCER SS WEINERT M MARTIN DF GIBBS D JERNIGAN J DUNN JP BARTLETT J BECKER R JABS DA JOHNSON DA LASALVIA S LESLIE J MAENZA J MILLER T NEISSER LG SEMBA RD TUCKER P BARRON B JARROTT C PEYMAN G SWENIE D HEINEMANN MH JANIS R POLSKY B SEPKOWITZ K FRIEDMAN AH GINSBURG R SEVERIN C TEICH S WALLACH F RESCIGNO R PAEZBOHAM R BUROFF E KLOSER P WANNER M FRIEDBERG DN ADDESSI A CHACHOUA A DIETERICH D HILL J HUTT R KAUL A LIGH J LORENZOLATKANY M PEI M POWERS T WEINBERG DV JAMPOL EM LYON AT MUNANA A MURPHY R PALELLA F RICHINE L STRUGALA Z VALADEZ G HOLLAND GN CARLSON ME CHAFEY SA HARDY WD JOHIRO AK MACARTHURCHANG LJ MARTIN MA MOE AA STRONG CA TUFAIL A UGALAT PS WEISZ JM FREEMAN WR AREVALOCOLINA JF CLARK T JARMAN CL MEIXNER L MENG TC SPECTOR S TASKINTUNA I TORRIANI FJ ODONNELL J ALFRED P BALLESTEROS F CLAY D COLEMAN R GORDON K GUMBLEY D HOFFMAN J IRVINE A JACOBSON M LARSON M MACALALAG L NARAHARA M PAYNE M SEIFF S WILSON S WOODRING H DAVIS J BLENKE A MADERA I MENDEZ P MURRAY T VANDERHORST C KYLSTRA J WOHL D ZIMAN K PAVAN PR GRIZZARD WS BERGEN GA COHEN SM CRAIG JA DEHLER RL ELBERT E FOX RW HAMMER ME HERNANDEZ LS HERRERA S HOLT D KEMP S LARKIN JA LEDFORD DK LOCKEY RF MENOSKY MM MILLARD S NADLER JP NELSON RP NORRIS D ORMEROD LD PAUTLER SE POBLETE SJ RODRIGUEZ D ROSENBACH KP SEEKINS DW TONEY JR DODGE JM KLEMSTINE JL SCHUERHOLTZ TA STEVENS M MEINERT CL AMENDLIBERCCI D COLESON L COLLINS KL COLLISON BJ DAWSON C DODGE J DONITHAN M EWING C FINK N GERCZAK C HARLE J HOLBROOK JT HUFFMAN R ISAACSON MR GILPIN AMK LANE M LEVINE CR MARTIN B MEINERT J MIN N NOWAKOWSKI DJ OWENS RM OZIEMKOWSKA MJ PIANTADOSI B SAAH A SMITH M TONASCIA J VANNATTA ML DAVIS MD ARMSTRONG J BRICKBAUER J BROTHERS R CHOP M HUBBARD L HURLBURT D KASTORFF L NEIDER M ONOFREY J STOPPENBACH V VANDERHOOFYOUNG M WALLS M HUGHES R KURINIJ N MOWERY RL ALSTON B FOULKES M NADLER PI WOOD DL BLADET M WU N CLARK T FEINBERG J FREEMAN W HOLBROOK J MCARTHURCHANG L DUNCAN WR KESSLER H LAMBERT AG POWDERLY W SCHNITTMAN S SPECTOR S BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR JP SMITH H WHITLEY R CHENG B FROST K MARCO M
Citation: Ra. Lewis et al., MSL-109 ADJUVANT THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY IN SYNDROME - THE MONOCLONAL-ANTIBODY CYTOMEGALOVIRUS RETINITIS TRIAL, Archives of ophthalmology, 115(12), 1997, pp. 1528-1536
PARENTERAL CIDOFOVIR FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - THE HPMPC PERIPHERAL CYTOMEGALOVIRUS RETINITIS TRIAL - A RANDOMIZED, CONTROLLED TRIAL
Authors: LEWIS RA CARR LM DOYLE K FAINSTEIN V GROSS R ORENGONANIA S SAMO TC SHIGLEY JW SPENCER SS WEINERT M DUNN JP BARTLETT J BECKER R FEINBERG J JABS DA JOHNSON DA LASALVIA S MILLER T NEISSER LG SEMBA RD TAYKEARNEY ML TUCKER P BARRON B JARROTT C PEYMAN G SWENIE D FRIEDMAN AH GINSBURG R SACKS H SEVERIN C TEICH S WALLACH F RESCIGNO R COWAN J HORAN C KLOSER P WANNER M FRIEDBERG DN ADDESSI A CHACHOUA A DIETERICH D HILL J HUTT R LIGH J LORENZOLATKANY M PEI M POWERS T SCOPPE C WEINBERG DV JAMPOL LM LYON AT MUNANA A MURPHY R PALELLA F RICHINE L STRUGALA Z VALADEZ G HOLLAND GN CARLSON ME CHAFEY S HARDY WD JOHIRO AK MACARTHURCHANG L MARTIN MA MOE AA STRONG CA TUFAIL A UGALAT PS WEISZ JM FREEMAN WR AREVALOCOLINA JF CLARK T JARMAN CL MEIXNER L MENG TC SPECTOR S TASKINTUNA I TORRIANI FJ ODONNELL J ALFRED P BALLESTEROS F CLAY D COLEMAN R GUMBLEY D HOFFMAN J IRVINE A JACOBSON M LARSON J MACALALAG L NARAHARA M PAYNE M SEIFF S WILSON S WOODRING H DAVIS J MENDEZ P MURRAY T SIMMONS T VANDERHORST C KYLSTRA J WOHL D ZIMAN K PAVAN PR BERGEN GA COHEN SM CRAIG JA DEHLER RL ELBERT E FOX RW GRIZZARD WS HAMMER ME HERNANDEZ LS HERRERA S HOLT D KEMP S LARKIN JA LEDFORD DK LOCKEY RF MENOSKY MM MILLARD S NADLER JP NELSON RP NORRIS D ORMEROD LD PAUTLER SE POBLETE SJ RODRIGUEZ D ROSENBACH KP SEEKINS DW TONEY JR DODGE JM KLEMSTINE JL SCHUERHOLTZ TA STEVENS M MEINERT CL AMENDLIBERCCI D COLESON L COLLINS KL COLLISON BJ DAWSON C DODGE J DONITHAN M EWING C FINK N GERCZAK C HARLE J HOLBROOK JT HUFFMAN R ISAACSON MR GILPIN AMK LANE M LEVINE CR MARTIN B MEINERT J NOWAKOWSKI DJ OWENS RM PIANTADOSI B SAAH A SMITH M TONASCIA J VANNATTA ML DAVIS MD ARMSTRONG J BRICKBAUER J BROTHERS R CHOP M HUBBARD L HURLBURT D KASTORFF L MAGLI Y NEIDER M ONOFREY J STOPPENBACH V VANDERHOOFYOUNG M WALLS M HUGHES R KURINIJ N MOWERY RL ALSTON B FOULKES M FREEMAN W HOLBROOK J MEINERT C MOWERY R POLSKY B DUNCAN WR KESSLER H LAMBERT AG POWDERLY W SCHNITTMAN S SPECTOR S BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR JP SMITH H WHITLEY R CHENG B FROST K MARCO M
Citation: Ra. Lewis et al., PARENTERAL CIDOFOVIR FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - THE HPMPC PERIPHERAL CYTOMEGALOVIRUS RETINITIS TRIAL - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 126(4), 1997, pp. 264
TREATMENT OF HISTOPLASMOSIS WITH FLUCONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: WHEAT J MAWHINNEY S HAFNER R MCKINSEY D CHEN DF KORZUN A SHAKAN KJ JOHNSON P HAMILL R BAMBERGER D PAPPAS P STANSELL J KOLETAR S SQUIRES K LARSEN RA CHEUNG T HYSLOP N LAI KK SCHNEIDER D KAUFFMAN C SAAG M DISMUKES W POWDERLY W
Citation: J. Wheat et al., TREATMENT OF HISTOPLASMOSIS WITH FLUCONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The American journal of medicine, 103(3), 1997, pp. 223-232
PILOT-STUDY OF TOPICAL TRIFLURIDINE FOR THE TREATMENT OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS HERPES-SIMPLEX-DISEASE IN PATIENTS WITH AIDS (ACTG-172)
Authors: KESSLER HA HURWITZ S FARTHING C BENSON CA FEINBERG J KURITZKES DR BAILEY TC SAFRIN S STEIGBIGEL RT CHEESEMAN SH MCKINLEY GF WETTLAUFER B OWENS S NEVIN T KORVICK JA VALENTINE F DEHOLCZER L WEAVER D POTTAGE J URBANSKI P BARTLETT JG BECKER R REXROAD V SCHOOLEY R RAY G POWDERLY W GOULD M ROYAL M CALO J COLEMAN R MARIUZ P WEISSMAN E BURK RA AVATO J MANGINI L GRIECO M
Citation: Ha. Kessler et al., PILOT-STUDY OF TOPICAL TRIFLURIDINE FOR THE TREATMENT OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS HERPES-SIMPLEX-DISEASE IN PATIENTS WITH AIDS (ACTG-172), Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 147-152
TREATMENT OF LYMPHOCUTANEOUS AND VISCERAL SPOROTRICHOSIS WITH FLUCONAZOLE
Authors: KAUFFMAN CA PAPPAS PG MCKINSEY DS GREENFIELD RA PERFECT JR CLOUD GA THOMAS CJ DISMUKES WE NEWMAN C POWDERLY W SCHELD M SHARKEYMATHIS PK CHAPMAN S HAMILL R LARSON R
Citation: Ca. Kauffman et al., TREATMENT OF LYMPHOCUTANEOUS AND VISCERAL SPOROTRICHOSIS WITH FLUCONAZOLE, Clinical infectious diseases, 22(1), 1996, pp. 46-50
SEQUENCE HETEROGENEITY OF NEF TRANSCRIPTS IN HIV-1-INFECTED SUBJECTS AT DIFFERENT STAGES OF DISEASE
Authors: RATNER L JOSEPH T BANDRES J GHOSH S VANDERHEYDEN N TEMPLETON A HAHN B POWDERLY W ARENS M
Citation: L. Ratner et al., SEQUENCE HETEROGENEITY OF NEF TRANSCRIPTS IN HIV-1-INFECTED SUBJECTS AT DIFFERENT STAGES OF DISEASE, Virology, 223(1), 1996, pp. 245-250
PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL
Authors: LEPORT C CHENE G MORLAT P LUFT BJ ROUSSEAU F PUEYO S HAFNER R MIRO J AUBERTIN J SALAMON R VILDE JL BLANC AP SCHMITT JL ARLAUD J ESTAVOYER JM GUILLEVIN L BENTATA M BEYLOT J LACUT JY GRANIER P COSNARD F BAZIN C DORMONT J REY M DELAUNAY C TROISVALLET D MICOUD M WEINBRECK P TREPO C GALLAIS H GASTAUT JA ALLARD C JANBON F CANTON P GROLLEAU JY CASSUTO J DELLAMONICA P DURET P FROTTIER J HERSON S SELIGMANN M SERENI D GIRAUDON BB DIEN G RUEL M STORCK D JAUBERT D LAFEUILLADE A MOUTON Y CHOUTET P LAFAIX C GATELL JM GUELAR A MILDVAN D SOIERO R JACOBSON JM MURRAY HW STEIGBIGEL NH SACHS HH VALENTINE F GRIECO MH ARMSTRONG D LEDERMAN M BARTLETT JA WASKIN HA NICHOLAS P FESSEL JW MACARTHUR RD GLATT AE PHAIR JP POWDERLY W HEWITT R STEIGBIGEL RT BLAIR DC SKAHAN KJ FRAME P CHEESEMAN SH CONNOR EM BALFOUR HH VANDERHORST C HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
THE TOLERABILITY AND PHARMACOKINETICS OF N-BUTYL-DEOXYNOJIRIMYCIN IN PATIENTS WITH ADVANCED HIV DISEASE (ACTG-100)
Authors: TIERNEY M POTTAGE J KESSLER H FISCHL M RICHMAN D MERIGAN T POWDERLY W SMITH S KARIM A SHERMAN J HIRSCH M
Citation: M. Tierney et al., THE TOLERABILITY AND PHARMACOKINETICS OF N-BUTYL-DEOXYNOJIRIMYCIN IN PATIENTS WITH ADVANCED HIV DISEASE (ACTG-100), Journal of acquired immune deficiency syndromes and human retrovirology, 10(5), 1995, pp. 549-553
PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: REICHMAN RC MORSE GD DEMETER LM RESNICK L BASSIAKOS Y FISCHL M PARA M POWDERLY W LEEDOM J GREISBERGER C NEVIN T WOOD K MEEHAN PM GEHEB H COX S BATTS D TIMPONE J SLACK A ROYAL M QUESADA NR GEISELER PJ STARK N NEIDIG J HILL M
Citation: Rc. Reichman et al., PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 171(2), 1995, pp. 297-304
RELATIONSHIP BETWEEN PLASMA-CONCENTRATIONS OF 3'-DEOXY-3'-FLUOROTHYMIDINE (ALOVUDINE) AND ANTIRETROVIRAL ACTIVITY IN 2 CONCENTRATION-CONTROLLED TRIALS
Authors: FLEXNER C VANDERHORST C JACOBSON MA POWDERLY W DUNCANSON F GANES D BARDITCHCROVO PA PETTY BG BARON PA ARMSTRONG D BRICMONT P KUYE O YACOBI A DESJARDINS R POLSKY B
Citation: C. Flexner et al., RELATIONSHIP BETWEEN PLASMA-CONCENTRATIONS OF 3'-DEOXY-3'-FLUOROTHYMIDINE (ALOVUDINE) AND ANTIRETROVIRAL ACTIVITY IN 2 CONCENTRATION-CONTROLLED TRIALS, The Journal of infectious diseases, 170(6), 1994, pp. 1394-1403
TRIMETREXATE WITH LEUCOVORIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FORMODERATE TO SEVERE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A PROSPECTIVE, CONTROLLED MULTICENTER INVESTIGATION OF THE AIDS-CLINICAL-TRIALS-GROUP PROTOCOL-029 031/
Authors: SATTLER FR FRAME P DAVIS R NICHOLS L SHELTON B AKIL B BAUGHMAN R HUGHLETT C WEISS W BOYLEN CT VANDERHORST C BLACK J POWDERLY W STEIGBIGEL RT LEEDOM JM MASUR H FEINBERG J BENOIT S EYSTER E GOCKE D BECK K LEDERMAN M PHAIR J REICHMAN R SACKS HS SOIERO R
Citation: Fr. Sattler et al., TRIMETREXATE WITH LEUCOVORIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FORMODERATE TO SEVERE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A PROSPECTIVE, CONTROLLED MULTICENTER INVESTIGATION OF THE AIDS-CLINICAL-TRIALS-GROUP PROTOCOL-029 031/, The Journal of infectious diseases, 170(1), 1994, pp. 165-172
THERAPY FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - A RANDOMIZED, PROSPECTIVE MULTICENTER STUDY OF ORAL FLUCONAZOLE VERSUS CLOTRIMAZOLE TROCHES
Authors: PONS V GREENSPAN D DEBRUIN M PORETZ D SUGAR A SQUIRES K LARSEN R SATTLER F REDDING S MACPHAIL L DODD C TUAZON C POWDERLY W COCHRAN J JOSEPH WP STERN J STEIGBIGEL R KOLETAR S FOLLANSBEE S AHERN MJ DAVIDSON M JOHNSON E CHAISSON R
Citation: V. Pons et al., THERAPY FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - A RANDOMIZED, PROSPECTIVE MULTICENTER STUDY OF ORAL FLUCONAZOLE VERSUS CLOTRIMAZOLE TROCHES, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1311-1316
METABOLIC RESPONSES TO HIV-1 INFECTION - CHANGES IN PLASMA-LEVELS OF AMINO-ACIDS
Authors: HORTIN GL LANDT M BADER S POWDERLY W
Citation: Gl. Hortin et al., METABOLIC RESPONSES TO HIV-1 INFECTION - CHANGES IN PLASMA-LEVELS OF AMINO-ACIDS, Blood, 82(10), 1993, pp. 10000415-10000415
Risultati: 1-21 |